期刊文献+

127例HIV-1B′亚型慢性感染者血浆中和水平及其与疾病进展的关系

Association of disease progression with neutralizing activity of plasma among 127 chronic HIV-1B′ infected individuals
原文传递
导出
摘要 目的探讨艾滋病病毒1型B′亚型(HI V-1 B′)慢性感染人群连续两年血浆中和能力的变化,及其与疾病进展的关系。方法通过对两年前后127例HI V-1 B′亚型感染者进行CD4和病毒载量(VL)的检测,采用基于TZM-b1细胞的中和实验方法,检测感染者血浆分别针对HI V-1临床分离株1597和实验室适应株SF33两种病毒的中和能力。通过分析中和50%病毒进入细胞的血浆浓度(EC50)与CD4计数和VL的相关性,阐明血浆中和水平与疾病进展的关系。结果2005年和2007年CD4分别为(454±131)个/μl和(440±182)个/μl(t=1.02,P=0.309),VL(log10)分别为(4.03±0.89)拷贝/ml和(4.21±0.89)拷贝/ml(t=2.72,P=0.008);血浆对1 597株有中和活性的分别有91例(71.65)和75例(66.93%),其EC50分别为(65.15±0.51)和(55.59±0.59)(t=1.16,P=0.248);对SF33株有中和活性的分别有108例(85.04%)和101例(85.04%),其EC50为(205.65±0.52)和(139±0.47)(t=3.57,P<0.001)。聚类分析显示,EC50与VL的关联性较强,但EC50的变化与VL的变化的相关性没有统计学意义(SF33∶r=0.07,P=0.41;1597∶r=0.12,P=0.18)。结论从2005年到2007年,慢性HI V-1B′亚型感染者的VL显著升高,尽管对病毒的中和水平降低,但血浆中和水平的降低与VL的升高没有直接的相关性。 Objective To study association of disease progression with neutralizing activity of plasma among 127 chronic HIV-1B′ infected former blood donors in Anhui province. Mechods The viral load(VL)and CD4 count were tested in 2005 and 2007 respectively, and the neutralizing activity of plasma against primary virus strain(1597) and labadapted strain(SF33)was also detected by using Luciferase assay system based on TZM- bl cell line. The plasma concentration of inhibiting 50 % of viruses to enter cells was expressed as EC50. The relation between EC50 and CD4 count or VL was analyzed respectively. Results The CD4 count was 454 ± 131 in 2005 and 440 ± 182 in 2007(t = 1.02,P = 0. 309), while the VL.(log10)was 4.03c/ml± 0,89 in 2005 and 4.21c/ml ± 0.89 in 2007(t = .272,P= 0.008).Out of the 127 cases under study, 91 (71.65 % )and 75(66.93 % )in their plasma had neutralizing activity against 1597 in 2005 and 2007, respectively while 108 (85.04%)and 101 in their plasma had neutralizing activity against SF 33 in the two respective years. EC50 against SF33 fell down from 205.65 ± 0.52 in 2005 to 139 ± 0.47 in 2007(t=3.56,P〈0.001),but EC50 against 1597 fell down only slightly from 65.15 ± 0.51 in 2005 to 55.59 ± 0.59 in 2007 (t = 1.16, P = 0. 248). Correlation analysis showed no significant correlation between falling EC50 and VL(SF33 : r = 0.07, P = 0.41 ; 1597 : r = 0.12, P = 0.18), although neutralizing activity had closer relationship with VL analyzed by the varcluster analysis. Conclusion From 2005 to 2007, plasma VL of the 127 chronic HIV-1B′ infected individuals showed significant rise, while the neutralizing activity against SF33 fell down. However, there was no statistical correlation between the decreasing EC50 and increasing VL.
出处 《中国艾滋病性病》 CAS 2009年第2期111-114,共4页 Chinese Journal of Aids & STD
基金 国家重点基础研究发展计划(973计划 2005CB523103) 国家自然基金(30872232) 中国综合性艾滋病研究项目(CIPRA U19AI51915) 盖茨基金(CAVIMC项目)
关键词 艾滋病病毒1型B′亚型 慢性感染 中和能力 疾病进展 HIV-IB′ chronic infection Neutralization Disease progression
  • 相关文献

参考文献13

  • 1Michael Huber, Marek Fischer, Benjamin Misselwitz, et al. Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection[J].PLoS Med,2006,3 ( 11 ) : 2078 - 2093. 被引量:1
  • 2Holl V, Peressin M, Decoville T, et al. Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells[ J ] . J Virol, 2006,80 (12) :6177 - 6181. 被引量:1
  • 3Douglas D Richman, Terri Wrin, Susan J Little, et al. Rapid evolution of the neutralizing antibody response to HIV type 1 infection [ J]. PNAS, 2003,100(7) : 4144 - 4149. 被引量:1
  • 4Wang Q, Shang H, Han X, et al. High level serum neutralizing anti-body against HIV-1 in Chinese long-term non-progressors.Microbiol Immunol[ J ] .2008,52(4) :209 - 15. 被引量:1
  • 5XU Jian-qing,WANG Jian-jun,HAN Li-feng,XU Chen,RUAN Yu-hua,XU Zhen-hou,CHEN Xi,LIU Zhen-dong,WANG Jun,SU Bing,DING Xin-ping,GAO Bing,GU Yong-bin,CAO Xiao-yun,XING Hui,HONG Kun-xue,PENG Hong,ZHAO Quan-bi,YUAN Lin,FENG Yi,ZHANG Gui-yun,MA Li-ying,WU Lan,SHAO Yi-ming.Epidemiology,clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province,China[J].Chinese Medical Journal,2006(23):1941-1948. 被引量:9
  • 6彭虹,徐建青,陈刚,洪坤学,邵一鸣.PLG-CD_4法测定HIV感染者CD_4 T细胞[J].中国艾滋病性病,2006,12(2):97-100. 被引量:7
  • 7GUO Yan-fang,MA Li-ying,YUAN Lin,WANG Shu-hua,SUN Jian-ping,XU Wei-si,Xu Jian-qing,XING Hui,HONG Kun-xue,ZHANG Xiao-yan,RUAN Yu-hua,ZHANG Yao-xin,SHAO Yi-ming.R5 to X4 coreceptor switch of human immunodeficiency virus type 1B' and B'/C recombinant subtype isolates in China[J].Chinese Medical Journal,2007(6):522-525. 被引量:7
  • 8Ming Li, Feng Gao, John R Mascola, et al. Human Immunodefieieney Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies[ J ] .J Virol,2005,79(16) : 10108 - 10125. 被引量:1
  • 9Naicker KP, Jiang S, Lu H, et al. Synthesis and anti-HIV-1 activity of 4-[ 4-( 4, 6-bisphenylamino-triazin-2-ylamino )-5-methoxy-2-methylphenylazo]-5-hydroxynaphthalene-2,7-disulfo nic acid and its derivatives[J].Bioorg Med Chem, 2004,12 ( 5 ) : 1215- 1220. 被引量:1
  • 10Moog, C, Fleury HJ, Pellegrin I, et al.Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals[J] .J Virol, i997,71 (5) :3734 - 3741. 被引量:1

二级参考文献22

  • 1WANGLan,ZHENGXi-wen,QIANHan-zhu,LüFan,XINGHui.Epidemiologic study on human immunodeficiency virus infection among children in a former paid plasma donating community in China[J].Chinese Medical Journal,2005(9):720-724. 被引量:9
  • 2Glencross D.,Scott LE.,Jani Ⅳ.et al.CD45-assisted PanLeucogating for accurate,cost-effective dual-platform CD4^+ T-cell enumeration[J].Cytometry,2002,50:69-77. 被引量:1
  • 3Glencross D.Dual Platform PanLeucogated(PLG) CD4^+ T cell enumeration[M].Afford CD4.com,2002. 被引量:1
  • 4Ping LH,Nelson JAE,Hoffman IF,Schock J,Lamers SL,Goodman M,et al.Characterization of V3 sequence heterogeneity in subtype C Human Immunodeficiency Virus type 1 isolates from Malawi:underrepresentation of X4 variants[].Journal of Virology.1999 被引量:1
  • 5Dragic,T.,Litwin,V.,Allaway,G.P.HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5[].Nature.1996 被引量:1
  • 6Pastore,C,Nedellec,R,Ramos,A,Pontow,S,Ratner,L,Mosier,DE.Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations[].Journal of Virology.2006 被引量:1
  • 7Jensen,M.A.,Li,F.-S.,van t,Wout,A.B.,Nickle,D.C.,Shriner,D.,He,H.-X.,McLaughlin,S.,Shankarappa,R.,Margolick,J.B.,Mullins,J.I.Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences[].Journal of Virology.2003 被引量:1
  • 8Shao Y.Report on the 2nd National HIV Molecular Epidemiology Survey[]..2004 被引量:1
  • 9Shao YM,Su L,Sun XH.Molecular epidemiology of HIV infection in China[].ⅫInternational conference on AIDS.1998 被引量:1
  • 10Cecilia D,KewalRamani VN,O‘Leary J,et al.Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage[].Journal of Virology.1998 被引量:1

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部